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Medicinal Plant Research in Malaysia: Scientific Interests and Advances 
IBRAHIM JANTAN 
ABSTRAK 
Kertas kerja ini menggariskan kecenderungan saintifik dan kemajuan dalam penyelidikan tumbuhan 
ubatan di Malaysia pada lima dekad yang lepas.  Pada mulanya minat utama program penyelidikan 
ialah kajian fitokimia yang membawa kepada penemuan sebatian bioaktif sebagai templet untuk 
menghasilkan calon dadah baru. Ketika pasaran ubatan herba di Malaysia mengalami pertumbuhan 
yang luar biasa, pendekatan penyelidikan baru-baru ini telah meliputi aktiviti untuk membangunkan 
ubatan herba menjadi produk yang berkualiti, berkesan dan selamat untuk penggunaan manusia.  
Kemajuan dalam teknik-teknik kromatografi dan spektroskopi telah memberi impak yang sangat besar 
ke atas pengasingan dan elusidasi struktur kandungan tumbuhan ubatan. Pembangunan siri kaedah 
bioassai dan penggunaan teknik pengasingan berpandukan bioassai telah menyumbang secara 
signifikan kepada kemajuan penyelidikan tumbatan ubatan di Malaysia.  Kajian ke atas beberapa 
tumbuhan ubatan yang dijalankan oleh saintis tempatan akan diilustrasi sebagai contoh. 
Kata kunci: Tumbuhan ubatan, penemuan dadah, ubatan herba, kajian fitokimia, bioassai, teknik 
kromatografi dan spektrometri. 
ABSTRACT 
This paper outlines the past five decades of  scientific interests and advances in medicinal plant 
research in Malaysia. Initially the prime interest of research programmes has been on phytochemical 
studies leading to the discovery of  biologically active compounds as chemical templates to produce 
new drug candidates. As the Malaysian herbal medicine market experiences an extraordinary growth, 
the research approaches taken have recently included activities to develop herbal medicines into 
quality, efficacious and safe products for human consumption. Advances in chromatographic and 
spectroscopic techniques have had a tremendous impact on the isolation and structure elucidation of 
the constituents of medicinal plants. The development of a series of bioassay methodologies and 
utilization of bioassay-guided isolation techniques have contributed significantly  to the progress of  
medicinal plant research in Malaysia. Research work on some medicinal plants carried out by the 
local scientists will be illustrated as examples.  
Keywords: Medicinal plants, drug discovery, herbal medicine, phytochemical studies, bioassays, 
chromatographic and spectroscopic techniques. 
INTRODUCTION 
Medicinal plants have been used by mankind as a source of medicines since time immemorial.  
Information on the ancient uses of plant materials as medicines can be found in archeological finds, old 
literature, history books  and pharmacopoeias.  In fact in the Quran and the Bible, about 20 and 125 
plants are mentioned, respectively, as being used as medicinal agents to treat various ailments 
(Musselman 1999).  More than 35,000 plant species have been reported to be used in various human 
cultures around the world for medical purposes (Lewington 1993).  However,  the number could be 
much higher as knowledge on the indigenous uses of plants was mostly passed on orally from one 
generation to another and has largely remained undocumented. Burkill (1966), in his extensive 
compilation of  the economic products of  the Malay peninsula, recorded not less than 1,300  plants 
have been used in traditional medicine.   
The tropical rain forest plants are biologically and chemically diverse resource as they synthesize 
various chemicals as defense agents against pests, diseases and predators. They are an excellent  
reservoir of medicines and chemical leads with which researchers can design and synthesize new drugs. 
In fact about 25% of the drugs used in modern medicine owe their origins to plants from tropical 
rainforest (Elliot 1986). The phytochemicals can be used unmodified as drugs,  as starting materials for 
the partial synthesis of drugs or as molecular models to synthesize new drugs. Of  the more than 120 
pure pharmaceutical chemicals isolated from  about 100 plant species, currently in use as drugs, 40 are 
obtained from tropical species (Farnsworth & Soejarto 1991).  However, fewer than 5% of tropical 
forest plant species have been examined for chemical compounds and medicinal values  (Zakrzewski 
2002). The figures are not unusual as systematic drug discovery programmes from plants are largely 
carried out by multinational drug corporations or research groups of the industrialized countries which 
possess the technology resources and well-equipped research facilities but have little access to the 
tropical plant genetic resources.  In most tropical countries there is little systematic research effort to 
screen plants for new drugs as their capacity to productively and sustainably exploit these resources to 
their full potential is limited; instead commercial activities such as clearing of forests for agricultural 
purposes and timber extraction predominate and are rapidly destructing the plant genetic resources.   
In the past five decades, medicinal plant research in Malaysia has been carried out mainly by 
researchers from government-funded universities and research institutes with little involvement of 
industries and multinationals. Although natural products screening programmes are still actively on 
going in these institutions, there is yet a serious effort to embark on a systematic drug discovery 
programme at a national level.  Most of the work on medicinal plants are inclined towards academic 
exercises with little emphasis on developmental approach.  Some of the promising initial findings have 
not been used for further research to the eventual development of new drugs. Limitation in funds, 
facilities, and qualified research personnel and lack of effective research management and collaboration 
between the research institutions have always been identified as the major stumbling-block to progress 
in drug research in Malaysia. The great public interest and expansion in the use of herbal medicine 
have led to new emphasis and drive in medicinal plant research. The research approaches taken have 
recently included activities to develop herbal medicines into quality, efficacious and safe products for 
human consumption.  
This paper is a review  of  the past five decades of  scientific interests and advances in medicinal 
plant research in Malaysia. Research work on some medicinal plants carried out by the local scientists 
will be illustrated as examples. 
THE EARLY YEARS – PHYTOCHEMICAL SCREENING ERA 
The selection of plant samples for phytochemical screening is generally based on the indigenous uses 
of plants.  In fact the  ethnobotanical approach is actually one of several methods that are applied in 
choosing plants for biological screening in a drug discovery programme. Other plant-collecting 
methods include the chemotaxonomic approach  or the phylogenetic survey where researchers choose 
close relatives of plants known to produce useful compounds and the ecological survey where selection 
is based on defensive characteristics of the plants against predators,  indicating they produce chemicals 
capable of exerting an effect on animals. The non-targeted approach i.e. random collection of plant 
samples is also carried out by researchers especially in areas supporting biological diversity.  The 
gathering of plant samples in Malaysia adopts all the above approaches but the more popular ones are 
the random and the ethnobotanical methods.  In the early years of medicinal plant research, collection 
of plants from the forests was carried out mainly by natural products chemists from the local 
universities for the purpose of finding plants for phytochemical screening.  It is necessary to record the 
important contributions of botanists in preparing voucher specimens, classification and identification of 
plant species for the phytochemical work   The voucher specimens are deposited at various herbariums 
in the local research institutions and universities including the Herbarium of the Forest Research 
Institute of Malaysia which has been recognized as the country’s national herbarium.  
The earliest report on medicinal plant research in Malaysia was on the phytochemical screening of 
205 plants in Sabah (Authur 1954), followed a few years later by the screening of 200 species in 
peninsular Malaysia for the presence of alkaloids (Douglas & Kiang 1957). These two publications 
marked the beginnings of medicinal plant research in Malaysia.  Subsequently, more plants were 
screened chemically for alkaloids, saponins, triterpenes and steroids (Kiang et al. 1961; Chan & Teo 
1969, 1972;  Carrick et al. 1968; Chan et al. 1977). This simple, cheap, sensitive, selective and rapid 
chemical tests to determine the presence of certain groups of compounds is an initial step to select 
plants for further phytochemical studies. In fact phytochemical screening is the earliest  step towards 
the identification of bioactive compounds for the discovery of new drugs. Such work continued to be 
published until recently by various research groups from the local universities and research institutions 
(Mohd Ali et al. 1982; Rahmani et al. 1985;  Lim et al. 1985; Lajis & Din, 1985; Said et al. 1987;  
Kiew et al. 1987; Teo et al. 1990; Jalil et al. 1995; Mohamed et al. 1995; Abu Said et al. 1995; Jusoh et 
al. 2003).   
The strong interest in phytochemical studies by a group of organic chemists from the local 
universities prompted them to organize annual meetings and workshops to present and discuss research 
findings in the field of natural products chemistry. The first such meeting was held in 1985 at 
Universiti Pertanian Malaysia and this was organized co-jointly with the Network for the Chemistry of 
Biologically Important Natural Products, Australia.  The meeting resulted in the publication of the 
Proceedings of the First Meeting of the Natural Product Research Group which contained articles on 
phytochemical surveys and ethnobotany (Din et al. 1985).  The meetings have since  been an annual 
event not only for phytochemists but also for natural products scientists from other disciplines to  
interact and  create strong working relationship amongst them and also exposed them to the current 
trend and progress in natural products research.  As a results of these meetings The Malaysian Natural 
Products Society was formed in 1994. UNESCO under its activity, the Regional Network for the 
Chemistry of Natural Products in South East Asia played important roles in supporting natural products 
research in Malaysia since the early seventies, especially in providing grants for scientists to organize 
and participate in regional seminars and conferences. Through this network, Malaysian scientists were 
able to interact and exchange information with researchers from other countries.  
PHYTOCHEMICAL STUDIES – ISOLATION OF COMPOUNDS AND  
THEIR STRUCTURE ELUCIDATION 
The main activities during the early years of medicinal plant research were basic phytochemical studies 
directed towards isolation of pure new compounds from selected medicinal plants and their structural 
elucidation. Most phytochemical studies were carried out to isolate alkaloids from families such as 
Lauraceae, Annonaceae, Rubiaceae and Apocynaceae since alkaloids were generally known to be 
biologically active and many natural drugs are alkaloids.  The researchers anticipated that the isolated 
compounds would be later assayed for biological activities and be further developed into new 
pharmaceutical agents.  The first report on phytochemical studies of Malaysian plants was on the 
isolation and structure elucidation of alkaloids of Uncaria pteropoda, and later that of Uncaria gambir.  
(Chan et al. 1966, 1968) 
A survey of the literature revealed that since the pioneering work of Chan and co-workers in the 
sixties there was no published work on the isolation and structure elucidation of phytochemicals of 
Malaysian plants until the early eighties which saw a revival of research. A workshop on the chemistry 
and structure elucidation of natural products was organized by UNESCO and Universiti Sains Malaysia 
in 1981. However, the papers presented in the workshop were general discussions on the chemistry of 
natural products, spectroscopic techniques used for structure elucidation and reviews of work carried 
out on plants from other countries (Feng et al. 1984).  There was a revival of research activity on 
medicinal plants in the later part of the eighties but at a slow pace. Some notable publications are the 
indole alkaloids of  Leuconotis species  (Goh et al. 1984, 1986a), the alkaloids of Uncaria callophylla 
(Goh & Ahmad Junan 1985), aporphine alkaloids of Desmos dasymachalus (Chan & Toh 1985) and 
Pseuduvaria macrophylla (Hadi et al. 1985), the alkaloids of Mitragyna speciosa (Houghton & Said 
1986) and goniothalamine oxide of Goniothalamus macrophyllus (Sam et al. 1987).   
The nineties saw a greater increase in the number of published work and this was in tandem with 
the small increase in number of people involved in phytochemical work. There were about 50 scientists 
actively involved in natural products research in the early nineties. Some of these publications could be 
found in proceedings of national seminars and international conferences held locally (Khozirah et al. 
1992; Chan et al. 1993; Said et al. 1996).  Kopsia species were one of the more popular plants that have 
been widely investigated by several workers for their alkaloidal contents since the early nineties 
(Awang et al. 1991; Sevenet et al. 1994; Uzir et al. 1997; Kam et al. 1993, 1994, 1996, 1999a, 1999b; 
Kam & Choo 2003). Examples of recent publications  are on a new dimeric stilbenoid from 
Neobalanocarpus heimii (Weber et al. 2001), coumarins from Malaysian Micromelum minutum 
(Rahmani et al. 2003) and alkaloids from Tabernaemontana corymbosa (Kam & Sim 2003) and 
Alstonia angustifolia (Kam & Choo 2004).   
The author contributed actively in the phytochemical studies of some Guttiferae species where 
several compounds were isolated including three new prenylated xanthones, a new neoflavonoid and a 
new biflavonoid (Goh & Ibrahim 1991; Goh et al. 1992a, 1992b, 1993). He was also involved in the 
study of aporphine alkaloids  of Aromadendron elegans (Goh & Ibrahim 1992) and diterpenoids of 
Andrographis paniculata (Ibrahim & Waterman 1994).  Recent work published in association with the 
author was the isolation of  new indole alkaloids with methyl chanofruticosinate skeletal system from 
Kopsia flavida (Husain et al. 2001). The structures of  all the compounds isolated were established on 
the basis of 2D NMR and other spectroscopic techniques.   
Systematic research to determine the chemical composition of new types of essential oils of 
Malaysian plants began actively in the late eighties by a few groups of  local scientists. The work has 
continued until the present time. The more notable work on essential oils was carried out by scientists  
from Universiti Kebangsaan Malaysia (Yaakob 1990, Yaakob et al. 1990; Din et al. 1989), Universiti 
Sains Malaysia (Wong et al. 1992, 1993, 1994) and the Forest Research Institute of Malaysia (Ibrahim 
1988; Ibrahim et al.1993, 1994a, 1995, 1996). The most important contributions by the author and co-
workers are a  series of publications on the essential oils of Cinnamomum species (Ibrahim et al. 
1990;1992; 1994b, 2002a, 2003, 2004). Prior to these reports on the essential oil constituents, there 
were earlier reports on the agronomic studies of a number of aromatic plants planted on experimental 
plots (Anonymous 1969) and on the physical and physico-chemical properties of  some popular spices 
to assess their qualities as compared to the ISO Standards (Mardi Report 1974a, 1974b, 1974c).   
ADVANCES IN CHROMATOGRAPHIC AND SPECTROSCOPIC TECHNIQUES 
In the early years of phytochemical work, isolation of compounds was carried out manually by the 
usual chromatographic techniques like open column chromatography, flash chromatography, vacuum 
liquid chromatography and preparative thin layer chromatography. Subsequent acquisition of newer 
automated liquid chromatographic techniques such as medium pressure liquid chromatography, reverse 
phase HPLC, chromatotron and  droplet counter current chromatography (DCCC) and the availability of 
pre-packed columns of  various polarity allowed many previously unworkable complex polar mixtures 
to be successfully fractionated and pure compounds to be isolated in higher yields. The use of capillary 
columns as alternatives to packed columns in GC together with GC-MS, equipped with extensive 
collection of library database, resulted in better resolution, faster and easier analysis of complex 
mixtures of biological origin. 
In the early years, structure elucidation posed a big problem to many researchers as the major 
spectroscopic equipment, i.e. nuclear magnetic resonance (NMR) and mass spectrometer (MS) were not 
easily available.  Many researches had to send samples  to institutions of developed countries  for these 
services.   The availability of these expensive spectroscopic instrument in many laboratories towards 
the late nineties facilitated and hastened elucidation of structures. Low fields 1H and 13C NMR (proton 
noise decoupling, off-resonance technique, DEPT), MS, IR,  UV spectra and elemental analysis data were 
in most cases sufficient  to obtain the structures of  compounds.   
The acquisition of new techniques such as two dimensional high field NMR, liquid chromatography 
– mass spectrometry (LCMS), chemical ionization and fast atom bombardment mass spectrometry (CI 
and FAB-MS), Fourier Transform Infra Red spectrophotometry (FTIR) and X-ray crystallography in the 
early nineties,  enabled natural products chemists to confidently characterized and identify structures of 
large and complicated molecules at  submilligram  quantities. The acquisition of high field NMR by 
some laboratories in the mid-nineties to run two-dimensional NMR experiments such as NOESY, HMQC, 
HMBC and J-modulated  has had a tremendous impact on the investigation of the constituents of 
medicinal plants in Malaysia.  
GENERAL SCREENING BIOASSAYS – THE BEGINNING OF A 
MULTIDISPLINARY APPROACH 
Phytochemical work for the sole purpose of studying the chemistry of isolated compounds phased out 
by the mid-eighties. Most phytochemists had been working in isolation with little interaction with 
scientists from other disciplines. The approach taken by many research groups gradually shifted from 
pure phytochemical screening to include biological screening which involved subjecting plant extracts 
or isolates to various bioassays to determine their biological activities. The phytochemists prepared 
plant extracts or isolated pure compounds which were then sent to biological scientists for bioactivity 
studies. This change was the beginning of a multidisciplinary approach in medicinal plant research in 
Malaysia.    
Ironically the first report on biological screening of Malaysian plants was way back in the sixties 
by a Japanese research group (Nakanishi et al. 1965). Since then there was little report on such 
publications until the late eighties.   The biological screening was limited by the bioassays available 
and little participation of biological scientists notably pharmacologists in medicinal plant research. 
Moreover the equipment used in most bioassays was expensive and research grants in this area of 
research were limited. The earlier assays that were commonly  in use were the general screening 
bioassays which were the simple, cheap and fast in vitro  bench-top bioassays particularly the brine 
shrimp lethality, insecticidal tests, antioxidant and antimicrobial assays. Toxicity screening of several 
plant extracts using the brine shrimp assay by Sam et al. (1988) is  one of the more notable work. Other 
examples of the brine shrimp lethality test on Malaysian plants are by Jalil et al. (1995), Husain et al. 
(1995) and Mohamed et al. (1995). The insecticidal activities of the extracts of some Shorea and 
Menispermaceae species (Mat Ali et al. 1988; Musa et al. 1988) and the larvicidal activity of some 
Malaysian plants on three vector mosquitoes (Ibrahim et al. 1996) have been reported.  Screening for 
antimicrobial and antioxidant activities on Zingiberaceae extracts has been carried out  (Habsah et al. 
2000). The author was also involved in the studies on the toxic and antifungal activities of the essential 
oils of Cinnamomum species (Ibrahim et al. 1994) and the antifungal activity of the essential oils of 
nine Zingiberaceae species (Ibrahim et al. 2003).    
NEW BIOASSAY METHODS 
The development and utilization of a series of specialized bioassays in many laboratories in Malaysia 
commenced in the early nineties. This was largely due to the increase in active participation of 
biological scientists especially pharmacologists, biochemists and microbiologists and the availability of 
substantial research grants from the Government through its Intensification of Research in Priority 
Areas (IRPA) programme which commenced in 1985.  Medicinal plant research was given a big boost 
when development and production of biopharmaceuticals from plants was identified as one of the 
priority areas. The new bioassay methods  include the use of in vitro systems such as cultured cells for 
anticancer, antiviral and antiparasitic assays, ex vivo systems involving isolated tissues and organs, in 
vivo systems involving whole animal experiments and the mode of action assays based on specific 
enzymes or receptors.   
Some examples of reports published in the eighties on biological activities of medicinal plants are 
the in vitro antihypertensive activity and cardiovascular effects  of alkaloids  isolated from several 
plants notably Uncaria callophylla (Goh et al. 1986b; Chang et al. 1989). In the following years the 
number of papers published on the biological activities of plant extracts and isolates from the local 
plants increased greatly. Some examples are the anti-tumor promoting activities of Zingiberaceae 
rhizomes (Vimala et al. 1999), the antimalarial activity of the extracts of Piper sarmentosum, 
Andrographis paniculata and Tinospora crispa (Nik Rahman et al. 1999), the antimicrobial, 
antioxidant, antitumour-promoting, cytotoxic and antifungal activities of Garcinia atroviridis 
(Mackeen 2000, 2002). 
The mode of action assays were becoming more popular because they were fast, easy to perform, 
quantitative and could selectively detect biologically active molecules at very low levels. The mode of 
action assays, employed in high-throughput screening (HTS) techniques, allow a large number of 
compounds to be screened for a wide range of bioactivities i.e. pharmacological, biochemical, 
microbiological, toxicological and immunological activities,  in a relatively short time. The approach 
taken by most research groups were to carry out bioactivity studies on crude extracts or isolated pure 
compounds. This approach has continued over the years and are still widely practiced until today by 
some research groups. Examples of work  carried out based on this approach are the inhibitory effects 
of xanthones, previously isolated from some Guttiferae species, on platelet-activating factor (PAF) 
binding to receptor in vitro (Ibrahim et al. 2001a), the mechanisms of apoptosis induced by 
goniothalamin,  isolated from Goniothalamus andersonii, in the leukemic T-cell line Jurkat and 
promyelocytic HL-60 leukemia cells (Inayat-Hussain et al. 1999, 2003), the effects of iridiods 
previously isolated from Saprosma scortechinii and Rothmannia macrophylla on lipoxygenase and 
hyaluronidase activities and their activation by beta-glucosidase in the presence of amino acids (Ling et 
al. 2003). 
BIOASSAY-GUIDED ISOLATION TECHNIQUES 
Recently, bioassay-guided isolation techniques were gradually adopted by many workers to isolate 
bioactive  compounds. In fact the systematic drug development  programmes from natural resources in 
multinational drug companies are based on the bioassay-guided isolation techniques. Fractionation of 
active extracts followed by isolation of active compounds are linked with bioassays and most of the 
time the compounds isolated are responsible for the biological activity of the plant. Bioassay-guided 
isolation of active compounds involves a strong collaboration between the chemist who is involved in 
the isolation and the biological scientist who is performing the assay. In some cases both the isolation 
and bioassay activities are carried out by the same scientist.  
The most active compound will be evaluated against the entire spectrum of molecular targets 
available in the laboratories to determine whether the compound is specific for  the desired target.  If 
the compound is found to interact with the entire family of related targets, its potential side effects or 
toxicity will be determined.  However,  to date very few publications resulted from the performance of 
this approach on Malaysian plants. Some examples of bioassay-guided isolation work carried out on 
Malaysian plants are isolation of reticulatacin, a new bioactive acetogenin from Annona reticulata 
(Saad et al. 1991), antimitotic and cytotoxic flavonols from Zieridium pseudobtusifolium and 
Acronychia porteri (Lichius et al. 1994), griffipavixanthone, a novel cytotoxic bixanthone from 
Garcinia griffithi and G. pavifolia (Xu et al. 1998), anti-inflammatory agents from Sandoricum 
koetjape (Mat Ali et al. 2004) and a potent PAF antagonist, a new alkenyl resorcinol from Ardisia 
elliptica (Jalil et al. in press). 
STRUCTURE-ACTIVITY RELATIONSHIP STUDY 
In a structure-activity relationship study (SAR),  a specific biological activity of structurally related 
compounds  is evaluated.  The most active compound with the least side effects will be selected as a 
lead structure for further development into a drug candidate. Structure-activity analysis of the tested 
compounds will determine the molecular structures responsible for the interactions with receptors on 
target organs. Eventually, the synthetic chemist will attempt to refine the SAR by synthesizing a series 
of compounds related to the most active structure, to improve the desired activity and to reduce or 
eliminate the unwanted biological activity. The lead compound in the class will be selected for total 
synthesis.   
SAR study is still at an infancy stage in Malaysia. There is only a few publications on structure-
activity analysis of compounds isolated from Malaysian plants. Lack of involvement of synthetic 
chemists to assist is the main reason for the slow progress in this area of medicinal plant research. The 
author  had been involved in the study on the inhibitory effects of a series of prenylated xanthones on 
PAF receptor binding in vitro. Structure-activity analysis of the compounds revealed that xanthones can 
represent a new class of natural products which can bind strongly to PAF receptor (Ibrahim et al. 2001a, 
2002b).   SAR study on inhibition of PAF receptor binding by aporphine alkaloids indicated that the 
flexibility of the biphenyl system of the aporphine and the presence of methoxy groups at C-9 and C-10 
were all preferable in binding to the receptor (Ibrahim et al. 2001b).   
TOXICOLOGICAL STUDIES 
The most active compound isolated from a plant by the bioassay-guided isolation will be subjected to 
pharmacological evaluation and a rigorous safety assessment procedures, involving testing against a 
large variety of different in vitro and in vivo tests which are designed to reveal different types of 
toxicity. The toxicity testing include acute toxicity, chronic toxicity, foetal toxicity, effect on fertility, 
mutagenic and carcinogenic responses. The compound will be tested on cell cultures and isolated 
tissues to examine any effects on cell reproduction and to identify its carcinogenic potential.  Several 
species of animals are administered with various levels of doses of  the compound to check for toxicity 
over a period of months.  If there are significant toxicity in the test animals, even at  very high doses of 
compound, further study on the compound will be discontinued. The activity of structurally related 
compounds will be similarly evaluated to determine whether the observed toxicity is due to any of the 
functional groups present in the class of compounds. More analogues of the compound need to be 
synthesized to finally discover  the most promising compound. The compound  which pass the toxicity 
testing is elevated to a drug candidate and is suitable to move on to clinical trials.  Example of 
toxicological studies on Malaysian plants are the teratogenic activity of goniothalamin and 
goniothalamin oxide from Goniothalamus opacus  in mice (Sam et  al. 1987), the  toxic activities of the 
essential oils of Cinnamomum species (Ibrahim et al. 1994) and the tumour promoting activity of plants 
used in Malaysian traditional medicine (Ilham et al. 1995).  
CLINICAL STUDIES 
The most active compound which passed through the safety assessment without any indication of 
toxicity in the preclinical studies will be subjected to clinical trials. Clinical trials, divided into four 
difference phases, involve testing the compound on healthy volunteers and patients. To date the only 
compound from Malaysian plant that has reached this stage of drug development was  calanolide A, 
isolated  from Calophyllum lanigerum (Soejarto et al. 1991).  The compound prevented the HIV-1-
induced cytopathic effects in human T-lymphoblastoid cells, especially halted HIV-replication 
(Kashman et al. 1992). Calanolide A was selected as a drug candidate for early clinical trials in the 
United States by the National Cancer Institute (NCI) (Soejarto et al. 1995).  
RESEARCH COLLABORATION WITH FOREIGN INSTITUTIONS 
Like other developing countries, Malaysia is still lacking in the capacity to develop its rich plant 
genetic resources to their full potential as pharmaceutical agents.  Neither is it capable of entering the 
pharmaceutical market on its own to compete with the multinational drug  corporations. The high cost 
of R & D and limitation in human and technology resources in drug research leave Malaysia with no 
choice but to collaborate with better equipped international research institutions or pharmaceutical 
companies.  
The publication by Teo et al. (1990) on the phytochemical screening of some plants  was the result 
of one of the earliest research collaboration between a local university with a foreign institution, i.e. 
University of Malaya and the Institut de Chimie des Substance Naturelles, France which started in 
1982. The participation of Japanese scientists in medicinal plant research in Malaysian research 
institutions and universities was through the Japan International Cooperation Agency (JICA) and the 
Japanese Society for the Promotion of Science (JSPS) mechanisms which  commenced in the late 
eighties. Malaysian scientists were given the opportunities to visit and participate in short-term research 
attachments at laboratories in Japan. The involvement of multinationals in  biological screening in the 
late eighties had subjected many Malaysian plants to systematic robotic HTS technology. This technique 
is based on testing the bioactivity of minute amount of compounds or fractions by means of single-
target specific assays using isolated enzymes or receptor binding, or multiple target functional 
bioassays using test animals, isolated organs or intact cells in a short time.  Biotics Limited, a UK-based 
biotechnology consultancy company, had a screening agreement with the Malaysian Forest Research 
and Development Board, where the latter supplied plant materials to pharmaceutical companies, Glaxo 
and SmithKline Beecham, for screening using advanced bioassay technology (Joffe & Thomas 1989). 
However, there was no significant output published based on this venture. 
The NCI started a collaboration with the Sarawak State Government in 1987 to collect plants for 
anticancer and anti-HIV screening  leading to the discovery of novel anti-HIV compounds, calanolide A 
and calanolide B  from Calophyllum lanigerum and C. teysmanii, respectively (Soejarto et al. 1991). 
Calanolide A was selected as a drug candidate for early clinical trials in the United States (Saejarto et 
al. 1995). This major discovery is a milestone in medicinal plant research in Malaysia and an eye-
opener on the need to collaborate with established research institutions of developed countries to 
increase the chances of success in a drug discovery programme. In 2000 the Ministry of Science, 
Technology and the Environment of Malaysia (MOSTE) supported the Malaysia-MIT Biotechnology 
Partnership Program (MMBPP), a five-year collaborative effort between Malaysian research institutions 
and Massachusetts Institute of Technology (MIT), to carry out research which include micropropagation 
of Eurycoma longifolia (Tongkat ali)  and chemical fingerprinting of ingredients in formulations of 
Tongkat ali and   enhancement of   bioactive metabolite production in Centella asiatica by chemical 
standardization and biological characterization (Anonymous 2004). 
HERBAL MEDICINE RESEARCH 
The Malaysian herbal product market is experiencing a tremendous growth.  Malaysia consumes RM 
1.2 billion worth of imported herbal products annually (Mohd Nor 1998). More people are turning to 
herbal products as alternative to the conventional therapeutic medicine or as nutritional and dietary 
supplements.  There is an increased trend of incorporating herbal therapy into modern medical practice 
by many mainstream healthcare professionals. Many of the herbal preparations claim to offer relief and 
prevention of adverse health conditions. However,  most of them are not satisfactorily provided with 
information on their ingredients, indications, dosage, pharmacology, contraindications and possible 
adverse health effects associated with prolonged use. There is concern for the lack of standardization of 
herbal preparations to guarantee their safety, quality and efficacy. Thus, there is an urgent need to 
conduct scientific research to provide experimental evidence of  safety, efficacy and quality of herbal 
medicines while also investigating the plants as sources for new lead structures for drug development.   
In response to the increased use of medicinal plants by the Malaysian population, the government 
in its 7th Malaysian Plan had identified several strategies to enhance the development of the local herbal 
industry. In 1995, FRIM was given the mandate to set up a National Committee on Medicinal Plants 
(NCMP) which was comprised of representatives from the universities, research institutions, government 
agencies and the local herbal industry. One of the major outputs of this collaborative effort was the 
publication of the  monograph on 20 selected medicinal plants (Zhari et al. 1999). However, due to 
lukewarm support from participating parties, there has not been much progress in the implementation 
of the  proposed master plan for R & D in herbal medicine research. The approval by the government 
of the establishment of the National Committee for Research & Development in Herbal Medicine 
(NRDHM) in 2002 led to the revival of the NCMP’s activities.  To date the committee has managed to 
come up with guidelines for levels and kinds of evidence to support claims, standardization, safety and 
clinical evaluations and intellectual property rights management. The five-year collaborative effort 
supported by MOSTE between Malaysian research institutions and MIT under the MMBPP, as mentioned 
earlier, contributed towards human resource development and training in herbal medicine research. The 
collaboration has recently resulted in the publication on genetic diversity of E. longifolia inferred from 
single nucleotide polymorphisms (Osman et al. 2003).  
In the 8th Malaysia plan, the government had allocated research funds under the IRPA mechanisms 
to embark on research programmes to put some of the more widely used medicinal plants such as 
Andrographis paniculata (Hempedu bumi), Labisia pumila (Kacip fatimah), Orthosiphon speciosa 
(Misai kucing), Morinda citrifolia (Mengkudu) and selected Zingiberaceae species under close 
scientific and clinical scrutiny. At present, five research groups comprising scientists from various 
academic and research institutions are actively involved in all aspects  of  herbal research on the above-
mentioned medicinal plants as follows: effective processing of medicinal plants for optimum 
production of herbal extracts; qualitative and quantitative analyses of herbal extracts for standardization 
and quality control purposes; pharmacognostic studies to develop monographs of medicinal plants for 
standard reference; in vitro and in vivo studies to determine biochemical, immunological, toxicological 
and pharmacological effects of herbal extracts; toxicological studies of herbal preparations; 
pharmacokinetic studies of herbal preparations; development of herbal medicines into modern 
pharmaceutical forms; clinical trials on standardized herbal preparations for various medical 
indications. 
CONCLUSIONS 
Despite the scientific interests and advances in the past five decades of medicinal plant research in 
Malaysia, to date efforts to discover new bioactive agents from the flora for use as chemical leads in 
the development of new drugs have not experienced much success. The scientific values of most local 
herbal preparations in terms of quality, safety and efficacy have yet to be established. There is a need to 
strategize research approach at the national level which should be based on the integration of human 
and technology resources available and the establishment of smart partnership between academic and 
research institutions, industries and multinational drug corporations. We have to learn from the 
experiences of the already successful research collaborations to increase the chances of success to 
discover new drugs from the Malaysian tropical rainforest.  Unless the right research strategy is 
pursued, it will take more than a few more decades for Malaysia to establish its research and drug 
design capacity and be a serious competitor in the pharmaceutical and herbal markets. We have to keep 
abreast with new technologies which are already playing  more important roles in medicinal plant 
research such as the advances in screening methodologies, the development of molecular biology and 
biotechnology and the use of computer technology in rational drug design.  The role of combinatorial 
chemistry in drug discovery and the future impact of genomics, proteomics and metabolomics in 
medicinal plant research should also be given due consideration. 
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